Should the United States Donate COVID Vaccine Doses to Less Rich Countries? Some want to wait until all consenting Americans can be vaccinated

Like the United States faces calls To share excess COVID-19 vaccine doses with less wealthy countries, a new study suggests Americans have divergent views on the appropriate levels and timing of so-called vaccine diplomacy.

Seniors in a survey of 788 U.S. adults were less likely to support higher levels of U.S. COVID-19 vaccine donation to low- and middle-income countries, and more likely to say they wanted to wait that all the United States that wanted their vaccines had been vaccinated, according to the study by researchers at Virginia Commonwealth University in the peer-reviewed journal Vaccine.

“This may be because older people are themselves a higher risk group and, therefore, might be more concerned about their own health or that of their peers,” the authors suggested.

Likewise, uninsured respondents were more likely to say they wanted to wait to donate until all consenting U.S. recipients had been vaccinated, and more likely to support while all high-risk Americans had been vaccinated. been vaccinated. This could indicate the concerns of economically vulnerable Americans over vaccine access, the authors wrote, “and speaks to the importance of developing and communicating a strong plan for equitable access to vaccines. in United States”

Meanwhile, Democrats self-identified in the study were more likely than Republicans to support higher levels of giving – consistent, according to the study, with Democrats’ support for universal health care and policies in the field. immigration more lenient.

Respondents who scored higher on the orientation of social dominance (a tendency to believe that “one’s own group should dominate and be superior to other groups,” as the study puts it) were also more likely to support until all Americans who wanted coronavirus vaccines were vaccinated and are less likely to want higher levels of donation. This characteristic, according to the authors, was “by far the greatest predictor.”

About eight in ten respondents said they supported donating at least 10% of future doses of the U.S. COVID-19 vaccine to the poorest countries, although nearly six in 10 said the doses should not. not be given until “at least a certain threshold of national vaccination has taken place.” . “

“Despite some hesitation among a minority of the sample, many respondents recognized the importance of closing the gap,” study co-author Bernard Fuemmeler, professor at VCU’s medical school, said in a press release. “Decision makers should be encouraged to have vaccine donation proposals accepted. “

That said, the authors cautioned that their sample’s quotas for race and ethnicity – which allowed them to compare demographic subgroups – might also have skewed a greater willingness to give doses. They cautioned that the percentages given were not representative of the US population.

But the findings still have implications for how U.S. policymakers and health professionals can build public support among different groups for donating vaccine doses overseas, the authors said – and how. how the messages should vary.

“More precisely, those who have a high [Social Dominance Orientation] beliefs are likely to be more effectively persuaded by messages exploiting American exceptionalism and the need to provide aid to the least developed, while those affiliated with the Democratic Party might be more persuaded by collectivist messages stressing that we are all in the same boat, ”they wrote. .

What the United States has done so far

President Biden scheduled for early March that the United States would have enough doses by the end of May to immunize every adult. “We want to be over-provisioned and over-prepared,” Jen Psaki, White House press secretary said before Biden’s announcement a few days later that the United States would buy an additional 100 million doses of Johnson & Johnson JNJ,
vaccine by the end of the year to allow “maximum flexibility”.

In the meantime, Biden faces the pressure from several corners to give extra doses to other countries, such as countries such as China and India have done as a form of diplomacy.

“We’re going to have an oversupply,” Zeke Emanuel, a University of Pennsylvania oncologist and bioethicist who helped develop the Affordable Care Act and advised Biden’s transition team, Axios said in March. “It would be unethical, and it would be a diplomatic and strategic error, to say that we have to buffer 100 million doses while China and Russia sell to people and say, you know, ‘You them. guy, count. “”

the administration of Biden, which re-engages the United States with the World Health Organization once the president has taken office, has so far said he would lend 4 million AstraZeneca AZN in total,
doses in Mexico and Canada, where regulators have licensed this vaccine, and contribute $ 4 billion in Covax, the global vaccine-sharing effort to ensure a more equitable distribution between low- and high-income countries.

Biden and the leaders of Japan, India and Australia (collectively known as the “Quad” alliance) also pledged to help the Indo-Pacific countries with vaccination, in particular thanks to the American financial support of the Indian manufacturer Biological E for the production of at least 1 billion doses of vaccine by the end of 2022.

Asked what additional steps the Biden administration plans to take – particularly in how to give vaccine doses – and when the administration would estimate they have enough vaccine to start giving doses overseas, a carrier White House word directed MarketWatch to Psaki’s comments during a separate briefing on March 22.

In response to a question about sharing vaccine doses, Psaki noted that the United States had been one of the countries hardest hit by the virus and said there were “still a number of factors unpredictable events that we need to plan to the best of our ability ”, such as the impact of variants and the best course of action for children, who are not yet eligible to receive the currently authorized Pfizer EFP,
Moderna mRNA,
and the Johnson & Johnson vaccines.

As the administration becomes convinced that its vaccine supply is sufficient, she added, it will explore options to share doses more widely.

“We fully recognize that in order to beat the pandemic on a global scale… the global community must be vaccinated. But there is a shortage of supply, at this stage, in the world, but also in the whole country, ”she said. “We’re not sitting on a secret dose of supplies. We’re trying to get them out as quickly as possible at this point. “

Source link

About Bernice Dyer

Bernice Dyer

Check Also

Christian rapper Flame to get $ 2.8 million from Katy Perry and her team after judge overturns copyright verdict

In July, a jury ruled that Katy Perry and her team had ripped off Christian …

Leave a Reply

Your email address will not be published. Required fields are marked *